Development and validation of an ultrasound-based AI-radiomics model for diagnosing and risk-stratifying gastrointestional stromal tumors: a retrospective diagnostic study

Accurate discrimination between gastrointestinal stromal tumors (GISTs) and leiomyomas is essential for guiding clinical management. This study developed and validated three predictive models: a baseline characteristics model (BCM), an endoscopic ultrasound-based morphological model (EUS-Morph), and a multimodal fusion model (MMF) incorporating clinical, EUS, and radiomics features. Their diagnostic performance in distinguishing GISTs from leiomyomas was systematically evaluated, along with their potential utility for GIST risk stratification. A retrospective analysis was conducted on 3,393 EUS images from 265 pathologically confirmed GIST/leiomyoma patients to differentiate tumors and stratify GIST risk. The diagnostic performance of various models was compared with each other and against endoscopists in the development cohort. We screened out several key independent variables that distinguish leiomyoma from GIST, including the Length/Short-axis (L/S) Ratio. After comparison, The MMF Model demonstrated optimal diagnostic and stratification performance, achieving the areas under the curve (AUC) values of 0.975 and 0.992, respectively. In contrast, the AUC range for diagnosing GIST by three experienced endoscopists was 0.68–0.70, and the AUC range for risk stratification was 0.72–0.74. Its performance in diagnosing GIST is over 40% higher than that of experienced endoscopists. All three developed AI models demonstrated favorable performance. Notably, the MMF model, which integrates patient baseline data, clinical characteristics, two-dimensional EUS images and radiomic features, effectively differentiated GISTs from leiomyomas GILs and achieved accurate risk stratification of GISTs. This EUS image-based integrated AI-radiomics model demonstrated improved diagnostic performance compared to endoscopists and may serve as a complementary tool in clinical practice.

Authors

Institutions

Publication Details

Journal
BMC Medical Imaging
Published
2025-11-27
DOI
https://doi.org/10.1186/s12880-025-02050-z
Citations
1
Primary Topic
Gastrointestinal Tumor Research and Treatment
Type
article
Field-Weighted Citation Impact
1.81

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Development and validation of an ultrasound-based AI-radiomics model for diagnosing and risk-stratifying gastrointestional stromal tumors: a retrospective diagnostic study

Hongzhang Wang, Liang Deng, Yang Liu, Xuemei He
1 citations
BMC Medical Imaging
Gastrointestinal Tumor Research and Treatment
1.81
article

Development and validation of an ultrasound-based AI-radiomics model for diagnosing and risk-stratifying gastrointestional stromal tumors: a retrospective diagnostic study

Hongzhang Wang, Liang Deng, Yang Liu, Xuemei He
article en
1 citations

Abstract

Accurate discrimination between gastrointestinal stromal tumors (GISTs) and leiomyomas is essential for guiding clinical management. This study developed and validated three predictive models: a baseline characteristics model (BCM), an endoscopic ultrasound-based morphological model (EUS-Morph), and a multimodal fusion model (MMF) incorporating clinical, EUS, and radiomics features. Their diagnostic performance in distinguishing GISTs from leiomyomas was systematically evaluated, along with their potential utility for GIST risk stratification. A retrospective analysis was conducted on 3,393 EUS images from 265 pathologically confirmed GIST/leiomyoma patients to differentiate tumors and stratify GIST risk. The diagnostic performance of various models was compared with each other and against endoscopists in the development cohort. We screened out several key independent variables that distinguish leiomyoma from GIST, including the Length/Short-axis (L/S) Ratio. After comparison, The MMF Model demonstrated optimal diagnostic and stratification performance, achieving the areas under the curve (AUC) values of 0.975 and 0.992, respectively. In contrast, the AUC range for diagnosing GIST by three experienced endoscopists was 0.68–0.70, and the AUC range for risk stratification was 0.72–0.74. Its performance in diagnosing GIST is over 40% higher than that of experienced endoscopists. All three developed AI models demonstrated favorable performance. Notably, the MMF model, which integrates patient baseline data, clinical characteristics, two-dimensional EUS images and radiomic features, effectively differentiated GISTs from leiomyomas GILs and achieved accurate risk stratification of GISTs. This EUS image-based integrated AI-radiomics model demonstrated improved diagnostic performance compared to endoscopists and may serve as a complementary tool in clinical practice.

BMC Medical ImagingVol. 25(1)
Chongqing University (CN), The Affiliated Yongchuan Hospital of Chongqing Medical University (CN), Chongqing Medical University (CN)
Chongqing Medical University
Openalex Percentile: Top 11%
Gastrointestinal Tumor Research and Treatment
1.81
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.